Rusakiewicz, S., Perier, A., Semeraro, M., Pitt, J. M., Pogge von Strandmann, E., Reiners, K. S., . . . Zitvogel, L. (2016). NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients. Oncoimmunology.
Citação norma ChicagoRusakiewicz, Sylvie, et al. "NKp30 Isoforms and NKp30 Ligands Are Predictive Biomarkers of Response to Imatinib Mesylate in Metastatic GIST Patients." Oncoimmunology 2016.
Citação norma MLARusakiewicz, Sylvie, et al. "NKp30 Isoforms and NKp30 Ligands Are Predictive Biomarkers of Response to Imatinib Mesylate in Metastatic GIST Patients." Oncoimmunology 2016.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.